| Cash Flow | 2025-08-31 |
|---|---|
| Gain on sale of business | 76,390 |
| Net income (loss) | 36,338 |
| Depreciation and amortization | 29,055 |
| Deferred income taxes | -5,830 |
| Share-based compensation | 4,962 |
| Loss on disposal of property and equipment | -699 |
| Amortization of debt issuance costs | 539 |
| Loss on refinancing and extinguishment of debt | -393 |
| Other | 382 |
| Accounts receivable, net | -17,607 |
| Inventories, net | 1,958 |
| Prepaid expenses and other current assets | -1,239 |
| Accounts payable and accrued liabilities | 14,169 |
| Interest expense accrual | -7,521 |
| Change in other non-current assets and non-current liabilities | 2,067 |
| Net cash provided by (used for) operating activities | 10,853 |
| Purchases of property, equipment and other non-current intangible assets | 24,002 |
| Proceeds from the maturities of marketable securities | 0 |
| Proceeds from sale of business, net of cash divested | 121,724 |
| Proceeds from the sale of property and equipment and other | 3 |
| Net cash provided by (used for) investing activities | 97,725 |
| Exercise of stock options and issuance of employee stock purchase plan shares | 905 |
| Tax payments related to share-based awards | 223 |
| Repayment of finance lease | 75 |
| Repayment of outstanding debt | 100,000 |
| Net cash (used for) provided by financing activities | -99,393 |
| Effects of foreign exchange rate on cash | 694 |
| Net increase (decrease) in cash and cash equivalents | 9,879 |
| Cash and cash equivalents at beginning of period | 129,004 |
| Cash and cash equivalents at end of period | 138,883 |
NEOGEN CORP (NEOG)
NEOGEN CORP (NEOG)